Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × fludarabine phosphate × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Myelodysplastic Syndromes 14 Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Non-Hodgkin 9 Multiple Myeloma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Lymphoma, Large B-Cell, Diffuse 7 Hematologic Neoplasms 7 Lymphoma, Mantle-Cell 6 Lymphoma, Follicular 6 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Leukemia 6 Hodgkin Disease 6 Melanoma 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, B-Cell 4 Leukemia, Myelomonocytic, Chronic 4 Hematologic Diseases 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Leukemia, Lymphoid 3 Leukemia, B-Cell 3 Anemia, Refractory, with Excess of Blasts 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Primary Myelofibrosis 2 Preleukemia 2

Interventions

11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡